Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-18-071391
Filing Date
2018-03-06
Accepted
2018-03-06 08:29:46
Documents
1
Effectiveness Date
2018-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 POS d544961ds8pos.htm S-8 POS 20661
  Complete submission text file 0001193125-18-071391.txt   21680
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-202860 | Film No.: 18668716
SIC: 2836 Biological Products, (No Diagnostic Substances)